Wingrove Theresa sold IMGN
January 16, 2024 · Form 4 insider transaction
Wingrove Theresa sold 187,667 shares of ImmunoGen, Inc. at $29.64 per share, a transaction worth $5.56M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Effected pursuant to a trading plan adopted on June 13, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.; The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.60 to $29.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.